BioCryst Reports Fourth Quarter and Full Year 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. BMY
8. FIX
9. TSCO
10. BE

Go back to BioCryst Reports Fourth Quarter and Full Year 2016 Financial Results

BioCryst Pharma (BCRX) Reports Q4 Loss Per Share of 6c

February 27, 2017 6:22 AM EST

BioCryst Pharma (NASDAQ: BCRX) reported Q4 EPS of ($0.06), $0.17 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $9 million versus the consensus estimate of $4.13 million.

For earnings history and earnings-related data on BioCryst Pharma (BCRX) click here.

... More